A Two-armed Real-world Study of Ozempic (OW Semaglutide) to Evaluate Its Adherence and Persistence Compared With Other Anti-diabetic Drugs Among Adult T2DM Patients in China

NCT07456774 · clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
100000
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Novo Nordisk A/S